Jung Jae Hwan, Jin Sung Giu
Department of Pharmaceutical Engineering, Dankook University, 119 Dandae-ro, Dongnam-gu, Cheonan, 31116 Republic of Korea.
Center for Bio‑Medical Engineering Core Facility, Dankook University, 119 Dandae-ro, Dongnam-gu, Cheonan, 31116 Republic of Korea.
J Pharm Investig. 2021;51(5):503-517. doi: 10.1007/s40005-021-00512-4. Epub 2021 Mar 4.
BACKGROUND: Transdermal delivery has the advantage of bypassing the first-pass effect and allowing sustained release of the drug. However, the drug delivery is limited owing to the barrier created by the stratum corneum. Microneedles are a transdermal drug delivery system that is painless, less invasive, and easy to self-administer, with a high drug bioavailability. AREA COVERED: The dose, delivery rate, and efficacy of the drugs can be controlled by the microneedle design and drug formulations. This review introduces the types of microneedles and their design, materials used for fabrication, and manufacturing methods. Additionally, recent biological applications and clinical trials are introduced. EXPERT OPINION: With advancements made in formulation technologies, the drug-loading capability of microneedles can be improved. 3D printing and digital technology contribute to the improvement of microneedle fabrication technology. However, regulations regarding the manufacture of microneedle products should be established as soon as possible to promote commercialization.
背景:经皮给药具有绕过首过效应并实现药物持续释放的优势。然而,由于角质层形成的屏障,药物递送受到限制。微针是一种经皮给药系统,无痛、侵入性小且易于自我给药,具有较高的药物生物利用度。 涵盖领域:药物的剂量、递送速率和疗效可通过微针设计和药物制剂来控制。本综述介绍了微针的类型及其设计、制造所用材料和制造方法。此外,还介绍了近期的生物学应用和临床试验。 专家观点:随着制剂技术的进步,微针的载药能力可以得到提高。3D打印和数字技术有助于微针制造技术的改进。然而,应尽快制定微针产品制造的相关法规以促进商业化。
J Pharm Investig. 2021
Eur J Pharm Biopharm. 2019-1-8
Expert Opin Ther Pat. 2020-6
Polymers (Basel). 2021-8-22
Pharmaceutics. 2022-12-1
Drug Deliv Transl Res. 2022-4
Biomed Pharmacother. 2018-11-9
Drug Deliv Transl Res. 2022-7
J Drug Target. 2013-4
Drug Deliv Transl Res. 2025-8-28
Polymers (Basel). 2025-7-18
Adv Healthc Mater. 2025-7-22
Int J Nanomedicine. 2025-7-4
RSC Adv. 2025-6-4
Pharmaceutics. 2025-4-28
Drug Des Devel Ther. 2025-5-10
Arch Pharm Res. 2025-5-7
J Control Release. 2020-6-10
Expert Opin Ther Pat. 2020-6
Adv Healthc Mater. 2020-2
J Control Release. 2020-1-10
Sci Adv. 2019-11-6
ACS Appl Mater Interfaces. 2019-11-8